Navidea Biopharmaceuticals Price to Sales Ratio 2010-2023 | NAVB
Historical PS ratio values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. The current P/S ratio for Navidea Biopharmaceuticals as of May 02, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Navidea Biopharmaceuticals P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2023-10-05 | 0.08 | 4012.15 | |
| 2023-09-30 | 0.09 | $0.00 | 0.00 |
| 2023-06-30 | 0.09 | $0.00 | 0.00 |
| 2023-03-31 | 0.26 | $0.00 | 0.00 |
| 2022-12-31 | 0.21 | $0.00 | 0.00 |
| 2022-09-30 | 0.25 | $0.00 | 0.00 |
| 2022-06-30 | 0.72 | $0.01 | 0.00 |
| 2022-03-31 | 0.79 | $0.01 | 56.92 |
| 2021-12-31 | 1.00 | $0.02 | 54.69 |
| 2021-09-30 | 1.75 | $0.03 | 67.97 |
| 2021-06-30 | 1.83 | $0.03 | 55.57 |
| 2021-03-31 | 2.02 | $0.04 | 56.30 |
| 2020-12-31 | 2.15 | $0.04 | 54.83 |
| 2020-09-30 | 2.70 | $0.04 | 70.46 |
| 2020-06-30 | 3.94 | $0.04 | 95.96 |
| 2020-03-31 | 0.76 | $0.05 | 14.48 |
| 2019-12-31 | 1.26 | $0.05 | 25.71 |
| 2019-09-30 | 0.69 | $0.05 | 12.61 |
| 2019-06-30 | 0.63 | $0.07 | 9.10 |
| 2019-03-31 | 2.76 | $0.11 | 24.53 |
| 2018-12-31 | 2.05 | $0.16 | 13.16 |
| 2018-09-30 | 4.61 | $0.17 | 27.18 |
| 2018-06-30 | 4.57 | $0.22 | 21.01 |
| 2017-12-31 | 7.17 | $0.22 | 32.43 |
| 2017-09-30 | 8.30 | $0.31 | 27.10 |
| 2017-06-30 | 10.20 | $0.31 | 32.61 |
| 2017-03-31 | 11.53 | $0.47 | 24.44 |
| 2016-12-31 | 12.75 | $0.55 | 23.11 |
| 2018-03-31 | 7.20 | $0.54 | 13.31 |
| 2016-09-30 | 18.31 | $-0.28 | 0.00 |
| 2016-06-30 | 10.61 | $0.02 | 655.98 |
| 2016-03-31 | 18.89 | $0.25 | 76.15 |
| 2015-12-31 | 26.60 | $0.41 | 65.29 |
| 2015-09-30 | 45.60 | $1.49 | 30.62 |
| 2015-06-30 | 32.20 | $1.26 | 25.58 |
| 2015-03-31 | 31.80 | $1.02 | 31.18 |
| 2014-12-31 | 37.80 | $0.84 | 44.87 |
| 2014-09-30 | 26.40 | $0.63 | 41.60 |
| 2014-06-30 | 29.60 | $0.40 | 73.80 |
| 2014-03-31 | 37.00 | $0.29 | 127.22 |
| 2013-12-31 | 41.40 | $0.19 | 221.40 |
| 2013-09-30 | 53.00 | $0.10 | 527.26 |
| 2013-06-30 | 53.40 | $0.03 | 1552.24 |
| 2013-03-31 | 54.20 | $0.01 | 3857.91 |
| 2012-12-31 | 56.60 | $0.02 | 3413.97 |
| 2012-09-30 | 55.00 | $0.02 | 3616.99 |
| 2012-06-30 | 74.40 | $0.07 | 1060.85 |
| 2012-03-31 | 65.60 | $0.06 | 1115.32 |
| 2011-12-31 | 52.40 | $0.13 | 388.26 |
| 2011-09-30 | 59.20 | $0.25 | 238.28 |
| 2011-06-30 | 66.40 | $0.23 | 287.89 |
| 2011-03-31 | 79.00 | $0.86 | 91.65 |
| 2010-12-31 | 41.20 | $1.46 | 28.27 |
| 2010-09-30 | 37.60 | $1.34 | 27.97 |
| 2010-06-30 | 36.00 | $2.00 | 17.98 |
| 2010-03-31 | 32.80 | $1.88 | 17.48 |
| 2009-12-31 | 24.40 | $1.76 | 13.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.004B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.482B | 26.59 |
| Intuitive Surgical (ISRG) | United States | $131.844B | 79.42 |
| Edwards Lifesciences (EW) | United States | $50.799B | 33.06 |
| DexCom (DXCM) | United States | $50.060B | 75.83 |
| IQVIA Holdings (IQV) | United States | $42.279B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $38.873B | 45.31 |
| Alcon (ALC) | Switzerland | $38.723B | 28.56 |
| STERIS (STE) | Ireland | $20.261B | 23.98 |
| Waters (WAT) | United States | $18.737B | 26.89 |
| Hologic (HOLX) | United States | $17.905B | 19.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.708B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.452B | 15.38 |
| ShockWave Medical (SWAV) | United States | $12.372B | 85.23 |
| Sysmex ADR (SSMXY) | Japan | $10.492B | 32.90 |
| Teleflex (TFX) | United States | $9.964B | 15.65 |
| Penumbra (PEN) | United States | $7.957B | 98.22 |
| Masimo (MASI) | United States | $7.091B | 39.77 |
| Globus Medical (GMED) | United States | $6.827B | 21.64 |
| Glaukos (GKOS) | United States | $4.964B | 0.00 |
| TransMedics (TMDX) | United States | $3.847B | 367.50 |
| Integer Holdings (ITGR) | United States | $3.678B | 22.22 |
| LivaNova (LIVN) | United Kingdom | $3.391B | 20.14 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.700B | 18.52 |
| Nihon Kohden (NHNKY) | Japan | $2.423B | 20.49 |
| Inari Medical (NARI) | United States | $2.419B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.337B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.294B | 9.41 |
| RxSight (RXST) | United States | $2.108B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.813B | 0.00 |
| Veracyte (VCYT) | United States | $1.539B | 0.00 |
| OPKO Health (OPK) | United States | $0.885B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.868B | 16.06 |
| Artivion (AORT) | United States | $0.838B | 96.81 |
| Paragon 28 (FNA) | United States | $0.817B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.795B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.738B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.594B | 20.18 |
| IRadimed (IRMD) | United States | $0.532B | 30.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.460B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
| NeuroPace (NPCE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.382B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.341B | 11.47 |
| AxoGen (AXGN) | United States | $0.287B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| CVRx (CVRX) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.90 |
| Alpha Tau Medical (DRTS) | Israel | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.087B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.059B | 120.33 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.053B | 0.00 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |